Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, Alexandria University, Egypt.
Department of Pathology, Faculty of Veterinary Medicine, Matrouh University, Marsa Matruh 51744, Egypt.
Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113469. doi: 10.1016/j.intimp.2024.113469. Epub 2024 Oct 29.
Diabetes mellitus (DM) represents a highly prevalent metabolic disorder across the globe. This study aimed to determine the ameliorative efficacy of glibenclamide (Gli) and obeticholic acid (OCA) against biochemical and pathological changes related to alloxan-induced diabetes. Twenty male Wistar rats were allocated into four groups; Control group, Diabetic group: received intraperitoneal injection of alloxan (120 mg/kg) for induction of diabetes, Diabetic + Gli group: Diabetic rats treated daily with oral Gli (5 mg/kg) and Diabetic + OCA group: Diabetic rats treated daily with oral OCA (10 mg/kg). All rats were subjected to 30 days treatments. Our results indicated that Gli successfully ameliorated hyperglycemia and dyslipidemia with a significant decline in serum pancreatic lipase activity and increased insulin level, while OCA had the same effect but without any enhancement in serum insulin levels. Additionally, the disturbances in liver function-related parameters and the evoked oxidative stress, interleukin(IL)-6 and IL-10 in the liver and pancreas were abrogated upon treatment with Gli and OCA. Furthermore, Gli and OCA increased AMP-activated protein kinase (P-AMPK), insulin receptor substrate 1 (IRS1), farnesoid X receptor (FXR), and glucagon-like peptide-1 receptor (GLP-1R) expressions and downregulated sterol regulatory element binding protein-1c mRNA expression. Besides, Gli and OCA have alleviated diabetes-induced histopathological distortions in hepatic and pancreatic tissues and enhanced the immunoexpression of insulin, and proliferating cell nuclear antigen with decreased immune reactivity of glucagon within pancreatic tissues. Gli and OCA decreased the immune reactivity of nuclear factor kappa B and increased the glycogen content of hepatic tissues. In conclusion, OCA is efficacious in the management of dyslipidemia and hyperglycemia of DM and its related oxidative stress.
糖尿病(DM)是一种在全球范围内普遍存在的代谢紊乱疾病。本研究旨在确定格列本脲(Gli)和奥贝胆酸(OCA)对丙烯醛诱导的糖尿病相关生化和病理变化的改善作用。将 20 只雄性 Wistar 大鼠分为四组:对照组、糖尿病组:腹腔注射丙烯醛(120mg/kg)诱导糖尿病,糖尿病+Gli 组:糖尿病大鼠每日口服Gli(5mg/kg)治疗,糖尿病+OCA 组:糖尿病大鼠每日口服 OCA(10mg/kg)治疗。所有大鼠均接受 30 天治疗。我们的结果表明,Gli 成功改善了高血糖和血脂异常,血清胰腺脂肪酶活性显著下降,胰岛素水平升高,而 OCA 具有相同的作用,但血清胰岛素水平没有任何提高。此外,Gli 和 OCA 治疗可消除肝功能相关参数的紊乱以及肝脏和胰腺中诱导的氧化应激、白细胞介素(IL)-6 和 IL-10。此外,Gli 和 OCA 增加了 AMP 激活蛋白激酶(P-AMPK)、胰岛素受体底物 1(IRS1)、法尼醇 X 受体(FXR)和胰高血糖素样肽-1 受体(GLP-1R)的表达,并下调了固醇调节元件结合蛋白-1c mRNA 的表达。此外,Gli 和 OCA 减轻了糖尿病引起的肝和胰腺组织的组织病理学扭曲,并增强了胰岛素和增殖细胞核抗原的免疫表达,同时降低了胰腺组织中胰高血糖素的免疫反应性。Gli 和 OCA 降低了核因子 kappa B 的免疫反应性,增加了肝组织的糖原含量。总之,OCA 可有效治疗糖尿病的血脂异常和高血糖及其相关的氧化应激。